Clinical Trial Update: EU PV for Retapamulin-Prescribing

View source ↗

Summary

This document reports a completed clinical trial update on retapamulin prescribing in the EU pharmacovigilance program for impetigo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo

Drugs mentioned

• Altabax (retapamulin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Impetigo | Status: COMPLETED